Loading viewer...
investor_presentation
Format: PDF investor_presentation
Halozyme Confidential and ProprietaryThird Quarter2022 Financialand Operating Results Nasdaq: HALO November 8, 2022
Halozyme Confidential and ProprietaryThird Quarter2022
Financialand Operating Results
November 8, 2022Halozyme Confidential and Proprietary 2
Inaddition tohistorical information, thestatements setforth inthispresentation include forward -looking statements including, without limitation, statements concerning the
Company’s expected future financial performance (including the Company's financial outlook for2022 )and expectations forprofitability, revenue (including
expectations forfuture milestones and royalties), operating income, and earnings -per-share, and theCompany’s plans torepurchase shares under itsshare repurchase
program and topotentially expand the Company's platform through acquisitions .Forward -looking statements regarding the Company’s ENHANZE®drug delivery
technology may include thepossible benefits and attributes ofENHANZE®including itspotential application toaidinthedispersion and absorption ofother injected
therapeutic drugs and facilitating more rapid delivery and administration oflarger volumes ofinjectable medications through subcutaneous delivery .Forward -looking
statements may also include potential growth driven byourand ourpartners' development and commercialization efforts (including anticipated new clinical trialstarts ,
pipeline advancements, product approvals and commercial launches ),projections forfuture sales revenue ofourpartners ’products, potential new ENHANZE®and other
collaborations ,collaborative targets and indications forENHANZE®products, co-formulation intellectual property and theCompany’s plans todevelop alarge volume
autoinjector and new formulations ofitsAPIforlonger intellectual property protection .These forward -looking statements aretypically, butnotalways, identified through
useofthewords "believe," "enable," "may," "will," "could," "intends," "estimate," "anticipate," "plan," "predict," "probable," "potential," "possible," "should," "continue," and other
words ofsimilar meaning and involve riskand uncertainties that could cause actual results todiffer materially from those intheforward -looking statements .Actual results
could differ materially from theexpectations contained inthese forward -looking statements asaresult ofseveral factors, including unexpected levels ofrevenues
(including royalty and milestone revenue received from ourcollaboration partners), expenditures and costs, unexpected delays intheexecution oftheCompany’s share
repurchase program ,unexpected results ordelays inthegrowth oftheCompany’s ENHANZE® business, obtaining new co-formulation intellectual property, orinthe
development, regulatory review orcommercialization ofnew formulations oftheCompany’s APIoritsproprietary orpartnered products, including any potential delays
caused bythecurrent COVID -19global pandemic, regulatory approval requirements, unexpected adverse events orpatient outcomes and competitive conditions .These
Preview truncated — download the full document for the complete content.
conference
20 Pages
investor_presentation
32 Pages
TriplePoint Venture Growth BDC Corporation